Kay Rispeter

975 citations
8 papers · 771 indexed · h-index 8
Topics
Hepatitis C virus research (8 papers)Monoclonal and Polyclonal Antibodies Research (6 papers)Hepatitis B Virus Studies (3 papers)
Partner nations
GermanyBrazilSlovakia

In The Last Decade

Kay Rispeter

8 papers receiving 761 citations

Peers

Kay Rispeter
Comparison fields: 5 of 36
  • Hepatology 650
  • Epidemiology 492
  • Radiology, Nuclear Medicine and Imaging 237
  • Immunology 162
  • Virology 148
Replace Isabelle Sheridan with:
Isabelle Sheridan United Kingdom
J. Eric Hall Netherlands
V. Lamonaca Italy
M.C. Jung Germany
Michelle Brown United States
Norbert H. Grüner Germany
Lionello Ruggeri Italy
Allan G. N. Angus United Kingdom
Laura L. Reyor United States
Ronda K. Sapp United States
Kay Rispeter relative to Isabelle Sheridan United Kingdom Isabelle Sheridan's profile →
Citations per field
00.5×2.6×
Isabelle Sheridan · 1×
Citations per year

Countries citing papers authored by Kay Rispeter

Since Specialization
Citations

This map shows the geographic impact of Kay Rispeter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay Rispeter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay Rispeter more than expected).

Fields of papers citing papers by Kay Rispeter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kay Rispeter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay Rispeter. The network helps show where Kay Rispeter may publish in the future.

Co-authorship network of co-authors of Kay Rispeter

This figure shows the co-authorship network connecting the top 25 collaborators of Kay Rispeter. A scholar is included among the top collaborators of Kay Rispeter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kay Rispeter. Kay Rispeter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 421
2 116
3 106
4 13
5 35
6 23
7 32
8 25

About Kay Rispeter

Kay Rispeter is a scholar working on Hepatology, Virology and Radiology, Nuclear Medicine and Imaging, having authored 8 papers that have together received 771 indexed citations. Recurring topics across this work include Hepatitis C virus research (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Hepatitis B Virus Studies (3 papers). The work is most often cited by research in Hepatology (650 citations), Virology (148 citations) and Epidemiology (492 citations). Kay Rispeter has collaborated with scholars based in Germany, Brazil and Slovakia. Frequent co-authors include Michael Roggendorf, Helga Meisel, Sergei Viazov, Jan M. Pestka, Peter Schürmann, Mirjam B. Zeisel, Birke Bartosch, Jens Baumert, Arvind H. Patel and Hubert E. Blum. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026